key: cord-1040972-t7bonus8
authors: Sureshchandra, Suhas; Zulu, Michael Z.; Doratt, Brianna M.; Jankeel, Allen; Tifrea, Delia; Edwards, Robert; Rincon, Monica; Marshall, Nicole E.; Messaoudi, Ilhem
title: Single cell RNA sequencing reveals immunological rewiring at the maternal-fetal interface following asymptomatic/mild SARS-CoV-2 infection
date: 2022-05-25
journal: Cell Rep
DOI: 10.1016/j.celrep.2022.110938
sha: e93c7f0a7d19f51abb7da403e2d98a2d5b69cae8
doc_id: 1040972
cord_uid: t7bonus8

While severe COVID-19 is associated with immune activation at the maternal-fetal interface, responses to asymptomatic/mild SARS-CoV-2 infection during pregnancy remain unknown. Here, we assess immunological adaptations in blood and term decidua in response to asymptomatic/mild disease in pregnant women. We report attenuated antigen presentation and type-I IFN signaling pathways, loss of tissue-resident decidual macrophages, and upregulated cytokine/chemokine signaling in monocyte-derived decidual macrophages. Furthermore, we describe increased frequencies of activated tissue-resident T-cells and decreased abundance of regulatory T-cells with infection while frequencies of cytotoxic CD4/CD8 T-cells are increased in the blood. In contrast to decidual macrophages, type-I IFN signaling is higher in decidual T-cells. Finally, infection leads to a narrowing of T-cell receptor diversity in both blood and decidua. Collectively, these observations indicate that asymptomatic/mild COVID-19 during pregnancy results in remodeling of the immunological landscape of the maternal-fetal interface, with a potential for long-term adverse outcomes for the offspring.

The current pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be a significant global threat . Overwhelming evidence suggests that pregnant women are a high-risk group for COVID-19 (Subbaraman, 2021) . Indeed, a study on severe COVID-19 infections in pregnant women from 18 countries has reported higher rates of adverse outcomes such as mortality, preeclampsia, and preterm birth (Villar et al., 2021) . While pregnant women with a severe COVID-19 diagnosis are at 62% higher odds of getting admitted to the ICU compared to non-pregnant women of reproductive age (Subbaraman, 2021; Yap et al., 2020) , a majority of those who get exposed to the virus experience asymptomatic or mild COVID-19 (Edlow et al., 2020b; Li et al., 2020; Lokken et al., 2020; Panagiotakopoulos et al., 2020) . Both vulnerability and immune responses to viral infections during pregnancy can be distinct compared to non-gravid individuals, as observed in influenza, hepatitis E, varicella, and measles (Jamieson et al., 2006; Kourtis et al., 2014; Sappenfield et al., 2013) . These differences are primarily driven by peripheral immune adaptations during pregnancy (Aghaeepour et al., 2017; Aghaeepour et al., 2018 ) that balance fetal tolerance and growth with host defense. A recent analysis of the peripheral immune system of mothers with asymptomatic disease revealed an increase in low-density neutrophils (LDN) but no gross changes in leukocyte frequencies, activation, or function (De Biasi et al., 2021) . Furthermore, the cytokine storm that is characteristic of severe COVID-19 in the general population is hardly reported in cases of severe COVID-19 amongst pregnant patients (Hojyo et al., 2020; Wang et al., 2020) . These findings support the hypothesis that pregnancy limits the induction of exuberant peripheral inflammatory responses to SARS-CoV-2 infection that are widely reported in non-pregnant individuals.

The immunological landscape of the maternal-fetal interface (placenta) undergoes significant changes during pregnancy. The decidual compartments of the placenta harbor maternal immune cells (macrophages, NK cells, and T cells (Vento-Tormo et al., 2018) ), which exhibit mixed signatures of activation and regulatory phenotype that correlate with gestation (van der Zwan et al., 2018) and can respond to foreign particles at the maternal-fetal interface (Ander et al., 2019) . However, details of decidual adaptations to a respiratory infection such as COVID-19 are slowly beginning to emerge. Although available data strongly suggest a lack of vertical transmission (Edlow et al., 2020b; Garcia-Flores et al., 2021; Schwartz and Morotti, 2020; Vivanti et al., 2020) with rare detection of viral RNA in the placenta (Edlow et al., 2020a) , severe COVID-19 has been shown to trigger maternal inflammatory responses at the maternal-fetal interface (Garcia-Flores et al., 2021; Lu-Culligan et al., 2021) . Specifically, an increase in markers J o u r n a l P r e -p r o o f associated with preeclampsia and activation of placental NK, T cells and increased expression of interferon-related genes and stress associated heat shock proteins have been reported (Lu-Culligan et al., 2021) . However, placental immune rewiring with asymptomatic/mild infections and how that relates to peripheral immune adaptations remains poorly understood.

Therefore, in this study, we examined the effect of maternal asymptomatic/mild SARS-CoV-2 infection occurring during late pregnancy on peripheral and decidual immune cells of the maternal-fetal interface at term. We used single-cell RNA-sequencing and multicolor flow cytometry to profile changes in the immune landscape of maternal decidua. Our analysis revealed an expansion of CD69+ T cells and selective loss of HLA-DR high regulatory macrophages and regulatory T cells (Tregs) with asymptomatic/mild SARS-CoV-2 infection in the decidua. Singlecell analysis revealed broad activation of myeloid cells in the decidua, with enrichment of cytokine secreting subsets, attenuation of interferon signaling, and a concomitant drop in expression of MHC class II molecules in blood monocyte-derived macrophage subsets. Activated T cells and terminally differentiated CD8 T cells (TEMRA) were enriched with infection, but an expansion of cytotoxic CD4 and antiviral CD8 T cells was only observed in the blood. While cytokine signaling modules were attenuated in the blood, elevated interferon signaling signatures persisted in the decidua. These findings highlight that even asymptomatic/mild infection can trigger placental immune activation with potential long-term consequences for the developing fetus.

J o u r n a l P r e -p r o o f

To comprehensively assess the impact of asymptomatic/mild SARS-CoV-2 infection on the immune landscape of the maternal-fetal interface, we collected decidua basalis (maternal membrane) and blood at delivery from mothers who experienced mild symptoms consistent with an upper respiratory tract infection not requiring medical care during pregnancy and had a positive SARS-CoV-2 PCR+ (mild) or those who tested positive during mandatory screening at the time of delivery but experienced no symptoms (asymptomatic) ( Figure 1A and Supp Table 1 ). We observed no differences in antibody titers (p=0.599 for NP IgG and p=0.87 for RBD IgG) between subjects in the mild and asymptomatic groups. Therefore, all subsequent analyses were performed on all SARS-CoV-2 exposed subjects (referred to as the asymptomatic/mild group) and compared to SARS-naïve healthy pregnant subjects (healthy donors, HD). No difference in age or body mass index was observed between SARS-CoV-2 exposed subjects and healthy donors. Blood samples were used to obtain complete blood counts and plasma antibody titers, and to assess changes in peripheral immune blood cell (PBMC) composition by flow cytometry ( Figure 1A ). Decidual immune cells were phenotyped using multispectral flow cytometry and single-cell RNA sequencing to assess immune perturbations at the maternal/fetal interface.

Complete blood cell counts indicated that absolute numbers of circulating granulocytes, monocytes, and platelets increased with infection, but no changes in lymphocyte numbers were detected (Supp Figure 1A) . Multicolor flow analysis of PBMC (Supp Figure 1B ) revealed a redistribution of naïve and memory T cell subsets in the absence of changes in total CD4 and CD8 T cell frequencies (Supp Figure 1C , D). Specifically, infection status was associated with a reduced abundance of naïve CD4 T cells but a modest expansion of central memory (TCM) (Supp Figure 1D ). Similar trends were observed in the CD8 subset where a modest reduction in naïve T cells was accompanied by increased frequency of effector (EM) and terminally differentiated effector memory (TEMRA) cells (Supp Figure 1D ). The frequency of total B cells and relative abundance of naïve/memory subsets did not vary significantly with infection (Supp Figure 1E ).

Although proportions of total NK cell did not vary with infection, the relative proportions of CD16 br CD56 dim expanded with infection while those of CD16+CD56+ subset decreased (Supp Figure 1F ). Similarly, while frequencies of total monocytes and dendritic cells (DCs) were comparable between the two groups (Supp Figure 1G) Flow analysis of decidual leukocytes revealed no changes in total T or B cell frequencies ( Figure 1B and Supp Figure 2A ). However, we observed a modest expansion of CD4 effector memory cells and a modest reduction in the CD8 naive T cells ( Figure 1C ) as well as frequencies of CD69+CD103-CD4 and CD8 tissue-resident T cells with asymptomatic/mild disease ( Figure   1D ). No differences in total decidual NK cell frequencies or subsets were observed (Supp Figure   2B ,C). However, proportions of both HLA-DR high macrophages and DCs decreased significantly with asymptomatic/mild infection ( Figure 1E ).

We next assessed the rewiring of immune (CD45+) cell states with asymptomatic/mild infection in an unbiased way at the single-cell resolution. Decidual leukocytes from 4 individuals per group were multiplexed using lipid tagged oligos (compatible with 3' single-cell gene expression), sorted to remove dead cells, and analyzed using single-cell RNA sequencing (scRNA seq) ( Figure 1A ). Following doublets and dead cell removal, dimension reduction, and clustering, our analysis identified 11 unique immune cell clusters (Figure 2A ). Cluster annotations were derived from differential marker analysis ( Figure 2B , Supp We next stratified clusters by SARS-CoV-2 exposure status ( Figure 2C and Supp Figure   3A ) and patient of origin (since the cells from each subject were barcoded using oligo tagged lipids) and compared cluster frequencies between the two groups (Supp Figure 3B) . whereas immune activation, adhesion associated terms were downregulated (Supp Figure 3H )

Interestingly, and in contrast to the flow cytometry data presented above, no differences in DC frequencies were detected from the scRNA Seq data (Supp Figure 3I) . However, as observed with flow cytometry, we observed a selective loss of HLA-DR high macrophages (dMac1)

with asymptomatic/mild SARS-CoV-2 infection ( Figure 2D ). Additional investigation on this subset revealed a high degree of heterogeneity, with the presence of 6 distinct macrophage states Although frequencies of dMac1 were reduced with infection ( Figure 2G ), IL1B+ dMac1 subset expressing cytokines IL1B, CCL3, CCL20 expanded with infection ( Figure 2G ). Moreover, robust gene expression changes were observed within both macrophage subsets in response to infection ( Figure 3A ). In dMac1 macrophages, infection was associated with the induction of genes involved in the antiviral response, viral sensing, NF-kB signaling, and cytokine production, while a small number of genes that play a role in myeloid cell activation and antigen processing and presentation were suppressed ( Figure 3B ). More robust gene expression differences were observed in dMac2 subset ( Figure 3A) , altering signatures associated with immune activation, upregulating genes involved in chemotaxis, cell death, and IL-17 signaling, and suppressing genes involved in antigen processing and presentation ( Figure 3C ).

We next compared scores for specific signaling pathways across both groups. SARS-CoV-2 infection was associated with an increase in module scores of cytokines and chemokine signaling ( Figure 3D ), notably NF-kB, TNF, and IL-17 signaling (Supp Figure 4A ) and pathogen sensing pathways such as TLR and RIG-I signaling (Supp Figure 4B ). The higher chemokine module score is illustrated by increased expression of several chemokine genes (such as CCL3, CCL3L1, CCL4, CXCL3, and CCL5), notably in dMac1 subset ( Figures 3D and 3E) . Interestingly, only dMac2 subset exhibited heightened IL-6 STAT signaling ( Figure 3D ) including an upregulation of inflammatory genes such as alarmins (S100A8, S100A9, S10012), TREM1, and cytokines (IL1A, IL1B, IL6) with infection ( Figure 3E ). Additionally, only dMac2 macrophage subset exhibited dampened type-I interferon signaling ( Figure 3D ) with key interferon-stimulated genes (IFIT2, GBP1, IRF1) downregulated with infection ( Figure 3F ).

Finally, we observed a differential impact of mild infection of MHC signaling in decidual macrophage subsets. Module scores for MHC class II signaling were upregulated in dMac1 but Interestingly, surface expression of activation markers CD40 and CD86 did not change with infection (Supp Figure 4D ). On the other hand, a higher expression level of M2 marker CD206 was detected on dMac1 macrophages, and modest increases in interferon receptor IFNAR1 expression were seen on both subsets (Supp Figure 4E ).

To investigate the impact of asymptomatic/mild SARS-CoV-2 infection in pregnant mothers on diverse T cell states within term placentas, we profiled sorted CD3+ T cells from decidual leukocytes and performed single-cell analysis (gene expression and T cell repertoire)

following multiplexing and feature barcoding (5' technology for parallel gene expression and T cell repertoire analyses), while simultaneously staining for CD4, CD8, CD45RA, tissue markers CD69 and CD103, and regulatory markers PD1 and CD25. Orthogonal readouts were measured in T cells from matched blood samples ( Figure 4A ). After doublets and ambient RNA removal, we identified 10 memory T cell clusters in addition to a naive cluster ( Figure 4B , Supp Table 3, Supp   Table 4 ) within the decidua. Both surface expression of CD4, CD8, CD69, CD103, CD25, and PD-1 from feature barcoding (Supp Figure 5A ) and highly expressed RNA markers (Figure 4C,   Supp Table 3, Supp Table 4 ), were used to annotate these memory T cell clusters. All memory CD4s expressed CD69, with three additional clusters expressing either high levels of PD-1 or RNA levels of HLA-DRA or KLRB1 (Supp Table 3 , Supp Table 4 Table   3 , Supp Table 4 ).

A modest reduction in naive T cells and a statistically significant reduction in regulatory T cell frequencies were observed with infection ( Figure 4D and Supp Figure 5C ). This reduction was accompanied by an overall expansion of CD69+ memory subsets (Supp Figures   5C and 5D ), as observed with flow cytometry ( Figure 1D ). Interestingly, a subset of activated CD4+CD69+HLA-DRA+ was significantly expanded with infection ( Figure 4D ). This subset of T cells, which was nearly absent in healthy donors, expressed high levels of genes involved in the J o u r n a l P r e -p r o o f regulation of viral processes, stress response, cell adhesion, and apoptosis ( Figure 4E ).

antiviral genes (OASL, ISG155, XAF1), heat shock proteins (HSPA6, HSPA8), but downregulation of Th2 genes (GATA3, PDE4D) ( Figure 4F ). Although frequencies of CD8 T cells subsets did not vary significantly with infection (Supp Figure 5E ), differential gene expression analysis revealed elevated signatures of T cell apoptosis, viral processes, myeloid leukocyte activation, and antigen processing and presentation (Figures 4G and 4H) . On the other hand, genes associated with NF-kB signaling were downregulated with infection (NFKBIA, CCL4) ( Figures 4G and 4H) . Finally, increased module scores for IL-2, type I interferon, and T cell signaling as well as T cell activation and exhaustion were observed with SARS-CoV-2 infection (Supp Figure 5F ).

We -Tormo et al., 2018) . Immune responses at the maternal-fetal interface are highly finetuned, balancing protecting the fetus from pathogens while also limiting excessive inflammatory exposure associated with stress or infection (Ander et al., 2019) . In vitro studies have demonstrated the ability of the virus to enter ACE2-expressing maternal and fetal cells in the placenta, however, this observation was not recapitulated in vivo (Verma et al., 2021) . Mild COVID-19 in the nongravid population is characterized by lymphopenia, albeit with a lower magnitude than that observed with severe disease . Patients with mild COVID-19 also experience an early increase in cytokines, but a progressive reduction in type-I and type-III interferon responses as well as increased levels of reparative growth factors (Lucas et al., 2020) . Furthermore, the increase in innate immune cell frequencies (monocytes, neutrophils, eosinophils) was less dramatic with moderate disease, suggesting a less inflammatory immune response with mild/moderate disease (Lucas et al., 2020) . In line with these previous observations, we report elevated frequencies of granulocyte, monocyte, and platelet but with no overt signs of lymphopenia. Moreover, as previously described (Arunachalam et al., 2020; Laing et al., 2020) , we show a reduction in plasmacytoid DCs (pDCs). Finally, we did not observe a redistribution of monocyte subsets or changes in the surface expression of HLA-DR and CD86

J o u r n a l P r e -p r o o f similar to a recent report (De Biasi et al., 2021) . The minimal immune activation may be driven by the Th2 bias observed with pregnancy (Aghaeepour et al., 2017) . Indeed, elevated plasma levels of regulatory IL-1RA and IL-10 were observed in pregnant women with asymptomatic disease (De Biasi et al., 2021) . This immune adaptation with pregnancy does not preclude pregnant women from developing an effective adaptive immune response to the virus since T cells from pregnant mothers with asymptomatic disease have been shown to be functionally competent with respect to ex vivo cytokine production and proliferation (De Biasi et al., 2021; Hsieh et al., 2022) . Similarly, we report a reduction in naïve CD4 T cells, and expansion of CD8 memory T cells (TEMRA), in addition to enrichment of cytotoxic CD4 and PD1+ antiviral CD8 T cells with infection.

Furthermore, antibodies against both RBD and NP were detected in the participants.

Severe COVID-19 disease during pregnancy has been recently shown to be associated with myeloid and T cell activation in the placenta (Lu-Culligan et al., 2021) . Here, we report broad myeloid cell activation in both macrophage subsets with asymptomatic/mild disease, albeit differential outcomes within the two decidual macrophage subsets-HLA-DR high (dMac1, tissueresident decidual macrophages) and HLA-DR low (dMac2, blood monocyte-derived decidual 

The main limitation of this study is the small sample size, which combined with the wide window of infectivity during pregnancy, the presence of samples from subjects with both asymptomatic and mild disease precluded the assessment of gestational age and disease severity on immunological outcomes. Given the limited amount of maternal blood obtained, we were unable to conduct a comprehensive measurement of antigen-specific T and B cell responses. Finally, it remains unclear if the placenta harbors virus-specific T cells that migrate from blood. Additionally, certain aspects of COVID-19 associated immune responses at the maternal-fetal interface such as IL-10 expression, antibody transfer, and ISG expression have been shown to be more prominent in mothers carrying male fetuses (Bordt et al., 2021) . Given the relatively small sample size of our study, we were unable to dissect fetal sex-specific adaptations in the placenta. 

The authors declare no competing interests. 

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Dr. Ilhem Messaoudi (ilhem.messaoudi@uky.edu)

This study did not generate new unique reagents.

• Single-cell RNA-seq data have been deposited at GEO and are publicly available as of the date of publication. Accession numbers are listed in the key resources table.

• This paper does not report original code.

• Additional Supplemental Items are available from Mendeley Data at http://dx.doi.org/10.17632/pxgb3cnxvd.1 • Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

This study was approved by the University of California Irvine Institutional Review Boards (Protocol ID HS# 2012-8716) and Oregon and Health Sciences University (eIRB# 22713 and 16328). Informed consent was obtained from all enrolled subjects. All participants in this study were healthy and did not report any significant comorbidities or complications with pregnancy.

Detailed characteristics of participants and experimental breakdown by samples are provided in Supp. Table 1 . Subjects with the asymptomatic disease are defined as those who tested positive during the mandatory screening at the time of admission to labor and delivery. Subjects with mild disease are defined as those who experienced (self-reported) symptoms consistent with mild upper respiratory tract infection but did not necessitate a hospital visit or stay or treatment.

Blood processing J o u r n a l P r e -p r o o f Whole blood samples were collected in EDTA vacutainer tubes. PBMC and plasma samples were isolated after whole blood centrifugation 1200 g for 10 minutes at room temperature in SepMate tubes (STEMCELL Technologies). Plasma was stored at -80 0 C until analysis. PBMC were cryopreserved using 10% DMSO/FBS and Mr. Frosty Freezing containers (Thermo Fisher Scientific) at -80C then transferred to a cryogenic unit 24 hours later until analysis.

Frozen PBMCs were thawed, washed in FACS buffer (2% FBS, 1mM EDTA in PBS), and counted on TC20 (Biorad) before surface staining using two independent flow panels. For the innate panel, for 1 hour. The disaggregated cell suspension was passed through tissue strainers to eliminate large tissue chunks. Cells were pelleted from the filtrate, passed through 70-um cell sieve, centrifuged, and resuspended in R3 media. Red blood cells were lysed using RBC lysis buffer (155 mM NH4Cl, 12 mM NaHCO3, 0.1 mM EDTA in double-distilled water) and resuspended in 5 mL R3 media. The cell suspension was then layered on a discontinuous 60% and 40% percoll gradient and centrifuged for 30 minutes with brakes off. Immune cells at the interface of 40% and 60% gradients were collected, washed in HBSS, counted, and cryopreserved for future analysis.

1-2 X 10 6 fresh decidual leukocytes were washed with PBS and stained using the following 

For 3' gene expression with CellPlex, raw reads were aligned and quantified using Cell Ranger (version 6.0.2, 10X Genomics) against the human reference genome (GRCh38) using the multi option and CMO information. Only singlets identified from each sample were included in J o u r n a l P r e -p r o o f downstream analyses. For 5' gene expression, alignments were performed using the feature and vdj option in Cell Ranger. Following alignment, hashing (HTO) and cell surface features (Antibody Capture) from feature barcoding alignments were manually updated in cellranger generated features file. Doublets were then removed in Seurat using the HTODemux function, which assigned sample identity to every cell in the matrix. Droplets with ambient RNA (cells with fewer than 400 detected genes), and dying cells (cells with more than 20% total mitochondrial gene expression) were excluded during initial QC. Data normalization and variance stabilization were performed on the integrated object using the NormalizeData and ScaleData functions in Seurat where a regularized negative binomial regression corrected for differential effects of mitochondrial and ribosomal gene expression levels. Dimension reduction was performed using RunPCA function to obtain the first 30 principal components and clusters visualized using Seurat's RunUMAP function. Cell types were assigned to individual clusters using FindMarkers function with a log2 fold change cutoff of at least 0.4 (FDR<0.05) and using a known catalog of wellcharacterized scRNA markers for human PBMC and decidual leukocytes. For T cells, 5' feature barcoding reads were normalized using centered logratio (CLR) transformation. Differential markers between clusters were then detected using FindMarkers function. A combination of gene expression and protein markers was used to define T cell subsets. CCR7 staining did not exhibit a significant positive peak, and hence was excluded from all downstream analyses. A list of cluster specific markers is provided in Supp Table 2 -4. Differential expression analysis was performed using the wilcoxon rank-sum test using default settings in Seurat. Only statistically significant genes (log10(fold change) cutoff ≥ 0.4; adjusted p-value ≤ 0.05) were included in downstream analyses. Module scores for specific gene sets were incorporated cluster-wise using AddModuleScores function.

TCR reads were aligned to VDJ-GRCh38 ensembl reference using Cell Ranger 6.0 (10X Genomics) generating sequences and annotations such as gene usage, clonotype frequency, and cell-specific barcode information. Only cells with one productive alpha and/or one productive beta chain were retained for downstream analyses. CDR3 sequences were required to have a length between 5 and 27 amino acids, start with a C, and not contain a stop codon. Clonal assignments from cellranger were used to perform all downstream analyses using the R package immunarch. Data were first parsed through repLoad function in immunarch, and clonality was examined using repExplore function. Family and allele level distributions of TRA and TRB genes J o u r n a l P r e -p r o o f were computed using geneUsage function. Diversity estimates (Hill numbers) were calculated using repDiversity function.

Data sets were first tested for normality using the Shapiro-Wilk test. Two-way comparisons for normally distributed data were tested for significance using an unpaired t-test with Welch's correction. For comparisons involving multiple groups, differences were tested using one-way ANOVA followed by Holm Sidak's multiple comparisons tests. P-values less than or equal to 0.05 were considered statistically significant. Values between 0.05 and 0.1 are reported as trending patterns. 

Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People

An immune clock of human pregnancy

A proteomic clock of human pregnancy

Immune responses at the maternal-fetal interface

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses

Clinical and immunological features of severe and moderate coronavirus disease 2019

Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection

Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic

Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic

Maternal-Fetal Immune Responses in Pregnant Women Infected with SARS-CoV-2

Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2

The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate

How COVID-19 induces cytokine storm with high mortality

SARS-CoV-2-specific T cell responses and immune regulation in infected pregnant women

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Emerging infections and pregnancy

Pregnancy and infection

A dynamic COVID-19 immune signature includes associations with poor prognosis

Maternal and Neonatal Outcomes of Pregnant Women With Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case-Control Study

Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State

SARS-CoV-2 infection in pregnancy is associated with robust inflammatory response at the maternal-fetal interface

Longitudinal analyses reveal immunological misfiring in severe COVID-19

SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics -Eight US Health Care Centers

Pregnancy and susceptibility to infectious diseases

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Placental Tissue Destruction and Insufficiency from COVID-19 Causes Stillbirth and Neonatal Death from Hypoxic-Ischemic Injury: A Study of 68 Cases with SARS-CoV-2 Placentitis from 12 Countries

Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2

Pregnancy and COVID: what the data say

Mixed signature of activation and dysfunction allows human decidual CD8(+) T cells to provide both tolerance and immunity

Single-cell reconstruction of the early maternal-fetal interface in humans

SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection The INTERCOVID Multinational Cohort Study

Transplacental transmission of SARS-CoV-2 infection

The role of a cytokine storm in severe COVID-19 disease in pregnancy

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Clinical manifestations, prevalence, risk factors, outcomes, transmission, diagnosis and treatment of COVID-19 in pregnancy and postpartum: a living systematic review protocol

We are grateful to all participants in this study. We thank the MFM Research Unit at OHSU for sample collection. We thank Dr. Jennifer Atwood for assistance with sorting at the flow cytometry core at the Institute for Immunology, UCI. We thank the UCI Genomics and High-Throughput Facility for assistance with 10X library sequencing. Aspects of experimental design figures were

• Asymptomatic and mild COVID-19 significantly remodels the maternal-fetal interface • Altered frequency of decidual macrophages, T-regs, and activated T cells • Antigen presentation and type I IFN signaling are attenuated in decidual macrophages • T cell repertoire diversity in circulation and decidua is reduced eTOC Sureshchandra et. al. describe extensive changes in blood and decidua obtained from pregnant women experiencing asymptomatic and mild SARS-CoV-2 infection. These data indicate that regardless of severity, COVID-19 remodels the maternal-fetal interface with potentially significant ramifications for pregnancy and neonatal outcomes.J o u r n a l P r e -p r o o f